Heart failure patients may get a boost: new drug combo targets exercise endurance
NCT ID NCT05138575
First seen Apr 25, 2026 · Last updated May 16, 2026 · Updated 6 times
Summary
This study tests whether two medications—empagliflozin and potassium nitrate—can help people with a type of heart failure (HFpEF) exercise longer. About 53 adults with stable heart failure will take these drugs to see if they improve muscle energy and blood flow. The goal is to find a way to ease symptoms and boost daily activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH PRESERVED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Pennsylvania Health System
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.